relation: http://publicatio.bibl.u-szeged.hu/29891/ title: Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations creator: Kállai Judit creator: Gindele Réka creator: Pénzes-Daku Krisztina creator: Balogh Gábor creator: Bogáti Réka creator: Bécsi Bálint creator: Katona Éva creator: Oláh Zsolt creator: Ilonczai Péter creator: Boda Zoltán creator: Róna-Tas Ágnes creator: Nemes László creator: Marton Imelda creator: Bereczky Zsuzsanna subject: 03.02. Klinikai orvostan description: Antithrombin (AT) is the major plasma inhibitor of thrombin (FIIa) and activated factor X (FXa), and antithrombin deficiency (ATD) is one of the most severe thrombophilic disorders. In this study, we identified nine novel AT mutations and investigated their genotype-phenotype correlations. Clinical and laboratory data from patients were collected, and the nine mutant AT proteins (p.Arg14Lys, p.Cys32Tyr, p.Arg78Gly, p.Met121Arg, p.Leu245Pro, p.Leu270Argfs*14, p.Asn450Ile, p.Gly456delins_Ala_Thr and p.Pro461Thr) were expressed in HEK293 cells; then, Western blotting, N-Glycosidase F digestion, and ELISA were used to detect wild-type and mutant AT. RT-qPCR was performed to determine the expression of AT mRNA from the transfected cells. Functional studies (AT activity in the presence and in the absence of heparin and heparin-binding studies with the surface plasmon resonance method) were carried out. Mutations were also investigated by in silico methods. Type I ATD caused by altered protein synthesis (p.Cys32Tyr, p.Leu270Argfs*14, p.Asn450Ile) or secretion disorder (p.Met121Arg, p.Leu245Pro, p.Gly456delins_Ala_Thr) was proved in six mutants, while type II heparin-binding-site ATD (p.Arg78Gly) and pleiotropic-effect ATD (p.Pro461Thr) were suggested in two mutants. Finally, the pathogenic role of p.Arg14Lys was equivocal. We provided evidence to understand the pathogenic nature of novel SERPINC1 mutations through in vitro expression studies. date: 2024 type: Folyóiratcikk type: PeerReviewed format: text identifier: http://publicatio.bibl.u-szeged.hu/29891/1/Kallai.pdf identifier: Kállai Judit; Gindele Réka; Pénzes-Daku Krisztina; Balogh Gábor; Bogáti Réka; Bécsi Bálint; Katona Éva; Oláh Zsolt; Ilonczai Péter; Boda Zoltán; Róna-Tas Ágnes; Nemes László; Marton Imelda; Bereczky Zsuzsanna: Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 25 (5). ISSN 1661-6596 (2024) identifier: doi:10.3390/ijms25052893 relation: https://doi.org/10.3390/ijms25052893 relation: 34742646 language: eng